NSAID use and decreased risk of gastrointestinal cancers

Gastroenterology Clinics of North America

Volumn 25, Issue 2, 1996, Pages 333-348

  Thun, M J ^a  

^a AMERICAN CANCER SOCIETY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; INDOMETACIN; NONSTEROID ANTIINFLAMMATORY AGENT; PIROXICAM; PROSTAGLANDIN; PROSTAGLANDIN SYNTHASE; SULINDAC;

ADENOMATOUS POLYP; CANCER PREVENTION; COLORECTAL CANCER; FAMILIAL POLYPOSIS; HUMAN; REVIEW;

EID: 0029896485     PISSN: 08898553     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8553(05)70250-8     Document Type: Article

References (71)

1. A. Bennett A. Civier C.N. Hensby Measurement of arachidonate and its metabolites extracted from human normal and malignant gastrointestinal tissues Gut 28 1987 315 318
2. A. Bennett M. Del Tacca I.F. Stamford Prostaglandins from tumours of human large bowel Br J Cancer 35 1977 881 884
3. P.A. Craven F.R. Derubertis Effects of aspirin on 1,-dimethylhydrazine-induced colonic carcinogenesis Carcinogenesis 13 1992 541 546
4. A.E. Davis F. Patterson Aspirin reduces the incidence of colonic carcinoma in the dimethylhydrazine rat animal model Aust NZ J Med 24 1994 301 303
5. R.N. DuBois Nonsteroidal anti-inflammatory drug use and sporadic colorectal adenomas Gastroenterology 108 1995 1310 1314
6. C.E. Eberhart R.J. Coffey A. Radhika Up-regulation of cyclooxygenase-2 gene expression in human colorectal adenomas and adenocarcinomas Gastroenterology 107 1994 1183 1188
7. W.G. Friend Sulindac suppression of colorectal polyps in Gardner's syndrome AFP 41 1990 891 894
8. E.M. Funkhouser G.B. Sharp Aspirin and reduced risk of esophageal cancer Cancer 76 1995 1116 1119
9. P.H. Gann J.E. Manson J. Glynn Low-dose aspirin and incidence of colorectal tumors in a randomized trial J Natl Cancer Inst 85 1993 1220 1224
10. F.M. Giardiello S.R. Hamilton A.J. Krush Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis N Engl J Med 328 1993 1313 1316
11. E. Giovanucci E.B. Rimm A. Ascherio Alcohol, low-methioninese, low-folate diets, and risk of colon cancer in men J Natl Cancer Inst 87 1995 265 273
12. E. Giovanucci E.B. Rimm M.J. Stampfer Aspirin use and risk for colorectal cancer and adenoma in male health professionals Ann Intern Med 121 1994 241 246
13. R.A.F. Gonzaga F.R. Lima S. Carneiro Sulindac treatment for familial polyposis coli [letter] Lancet 1 1985 751
14. E.R. Greenberg J.A. Baron D.H. Freeman Reduced risk of large-bowel adenomas among aspirin users J Natl Cancer Inst 85 1993 912 916
15. G. Gridley J.K. McLaughlin A. Ekbom Incidence of cancer among patients with rheumatoid arthritis J Natl Cancer Inst 85 1993 307 311
16. C.W. Heath M.J. Thun E.R. Greenberg Nonsteroidal anti-inflammatory drugs and human cancer Cancer 74 1994 2885 2888
17. W.C. Hubbard M.C. Alley T.L. McLemore Profiles of prostaglandin biosynthesis in sixteen established cell lines derived from human lung, colon, prostate and ovarian tumors Cancer Res 48 1988 4770 4775
18. H.A. Isomaki T. Hakulinen U. Joutsenlahti Excess risk of lymphomas, leukemia and myeloma in patients with rheumatoid arthritis J Chron Dis 31 1978 691 696
19. B.M. Jaffe Prostaglandins and cancer: An update: Prostaglandins 6 1974 453 461
20. T. Kudo T. Narisawa S. Abo Antitumor activity of indomethacin on methylazoxymethanol-induced large bowel tumors in rats Jpn J Cancer Res 71 1980 260 264
21. G. Kune S. Kune L. Watson Colorectal cancer risk, chronic illnesses, operations, and medications: Case control results from the Melbourne Colorectal Cancer Study Cancer Res 48 1988 4399 4404
22. D. Labayle D. Fisher P. Vielh Sulindac causes regression of rectal polyps in familial adenomatous polyposis Gastroenterology 101 1991 635 639
23. J. Ladenheim G. Garcia D. Titzer Effect of sulindac on sporadic colonic polyps Gastroenterology 108 1995 1083 1087
24. A. Lipton S. Scialla H. Harvey Adjuvant antiplatelet therapy with aspirin in colorectal cancer J Med 23 1982 419 429
25. R.F.A. Logan J. Little P.G. Hawtin Effect of aspirin and non-steroidal anti-inflammatory drugs on colorectal adenomas: Case-control study of subjects participating in the Nottingham faecal occult blood screening programme BMJ 307 1993 285 289
26. L.J. Marnett Aspirin and the role of prostaglandins in cancer Cancer Res 52 1992 5575 5589
27. Martinez ME, McPherson RS, Levin B: Aspirin and other nonsteroidal anti-inflammatory drugs and risk of colorectal adenomatous polyps among endoscoped individuals [abstr]. Presented at American Society of Preventive Oncology, Houston, 1995
28. 2 by tissue-fixed macrophages in colonic carcinoma Digestion 47 1990 160 166
29. E. Mereto L. Frencia M. Ghia Effect of aspirin on incidence and growth of aberrant crypt foci induced in the rat colon by 1, 2-dimethylhydrazine Cancer Lett 76 1994 5 9
30. U. Metzger J. Meier G. Uhlschmid Influence of various prostaglandin synthesis inhibitors on DMH-induced rat colon cancer Dis Colon Rectum 27 1984 366 369
31. M. Moorghen P. Ince K. Finney A protective effect of sulindac against chemically-induced primary colonic tumors in mice J Pathol 156 1988 341 347
32. A.D. Müller A. Sonneberg I.H. Wasserman Diseases preceding colon cancer: A case-control study among veterans Dig Dis Sci 39 1994 2480 2484
33. J.E. Muscat S.D. Stellman E.L. Wynder Nonsteroidal antiinflammatory drugs and colorectal cancer [see comments] Cancer 74 1994 1847 1854
34. 2) against indomethacin J Cancer Res Clin Oncol 108 1984 239 242
35. 2 and liver and lung metastases in colorectal cancer Dis Colon Rectum 33 1990 840 845
36. T. Narisawa M. Sato M. Tani Inhibition of development of methylnitrosourea-induced rat colon tumors by indomethacin treatment Cancer Res 41 1981 1954 1957
37. T. Narisawa M. Satoh M. Sano Inhibition of initiation and promotion by N-methylnitrosourea-induced colon carcinogenesis in rats by non-steroid anti-inflammatory agent indomethacin Carcinogenesis 4 1983 1225 1227
38. D.N. Nigro A.W. Bull M.E. Boyd Inhibition of intestinal carcinogenesis in rats: Effects of difluoromethylornithine with piroxicam or fish oil J Natl Cancer Inst 77 1986 1309 1313
39. A. Paganini-Hill Aspirin and colorectal cancer: The Leisure World cohort revisited Prev Med 24 1995 113 115
40. A. Paganini-Hill A. Chao R.K. Ross Aspirin use and chronic diseases: A cohort study of the elderly BMJ 229 1989 1247 1250
41. I.I. Peleg H.T. Maibach S.H. Brown Aspirin and nonsteroidal anti-inflammatory drug use and the risk of subsequent colorectal cancer Arch Intern Med 154 1994 394 399
42. P. Peltomaki L.A. Aaltonen P. Sistonen Genetic mapping of a locus predisposing to human colorectal cancer Science 260 1993 810 818
43. M. Pollard Antitumor effect of indomethacin in rats with autochthonous intestinal tumors B. Levin R.H. Riddell Frontiers in Gastrointestinal Cancer 1984 Elsevier New York 91 103
44. M. Pollard P.H. Luckert Indomethacin treatment of rats with dimethylhydrazine-induced intestinal tumors Cancer Treat Rep 64 1980 1323 1327
45. M. Pollard P.H. Luckert Effect of indomethacin on intestinal tumors induced in rats by the acetate derivative of dimethylnitrosamine Science 214 1981 558 559
46. M. Pollard P.H. Luckert Treatment of chemically-induced intestinal cancers with indomethacin Proc Soc Exp Biol Med 167 1981 161 164
47. M. Pollard P.H. Luckert Prolonged antitumor effect of indomethacin on autochthonous intestinal tumors in rats J Natl Cancer Inst 70 1983 1103 1105
48. M. Pollard P.H. Luckert Effect of piroxicam on primary intestinal tumors induced in rats by N-methylnitrosourea Cancer Lett 25 1984 117 121
49. M. Pollard P.H. Luckert Prevention and treatment of primary intestinal tumors in rats by piroxicam Cancer Res 49 1989 6471 6473
50. M. Pollard P.H. Luckert M.A. Schmidt The suppressive effect of piroxicam on autochthonous intestinal tumors in the rat Cancer Lett 21 1983 57 61
51. C.V. Rao A. Rivenson B. Simi Chemoprevention of colon carcinogenesis by sulindac, a nonsteroidal anti-inflammatory agent Cancer Res 55 1995 1464 1472
52. C.V. Rao K. Tokumo J. Rigotty Chemoprevention of colon carcinogenesis by dietary administration of piroxicam, α-difluoromethylornithine, 16-fluoro-5-androsten-17-one, and ellagic acid individually and in combination Cancer Res 51 1991 4528 4534
53. B.S. Reddy H. Maruyama G. Kelloff Dose-related inhibition of colon carcinogenesis by dietary piroxicam, a nonsteroidal anti-inflammatory drug, during different stages of rat colon tumor development Cancer Res 47 1987 5340 5346
54. B.S. Ready J. Nayini K. Tokumo Chemoprevention of colon carcinogenesis by concurrent administration of piroxicam, a nonsteroidal anti-inflammatory drug with D, L,-difluromethylornithine, an ornithine decarboxylase inhibitor, in diet Cancer Res 50 1990 2562 2568
55. B.S. Reddy C.V. Rao A. Rivenson Inhibitory effects of aspirin on azoxymethane-induced colon carcinogenesis in F344 rats Carcinogenesis 14 1993 1493 1497
56. B.S. Reddy K. Tokumo N. Kulkarni Inhibition of colon carcinogenesis by prostaglandin synthesis inhibitors are related compounds Carcinogenesis 13 1992 1019 1023
57. B. Rigas I.S. Goldman L. Levine Altered eicosanoid levels in human colon cancer J Lab Clin Med 122 1993 518 523
58. J. Rigau J.M. Pigué E. Rubio Effects of long term sulindac therapy on colonic polyposis Ann Intern Med 115 1991 952 954
59. L. Rosenberg J.R. Palmer A.G. Zauber A Hypothesis: Nonsteroidal anti-inflammatory drugs reduce the incidence of large-bowel cancer J Natl Cancer Inst 83 1991 355 358
60. C.A. Rubio B. Wallin J. Ware Effect of indomethacin in autotransplanted colonic tumors Dis Colon Rectum 32 1989 488 491
61. D.M. Schreinemachers R.B. Everson Aspirin use and lung, colon, and breast cancer incidence in a prospective study Epidemiology 5 1994 138 146
62. S.A. Skinner A.G. Penney P.E. O'Brian Sulindac inhibits the rate of growth and appearance of colon tumors in the rat Arch Surg 126 1991 1094 1096
63. O. Suh C. Mettlin N.J. Petrelli Aspirin use, cancer, and polyps of the large bowel Cancer 72 1993 1171 1177
64. M.J. Thun Aspirin, NSAIDs, and digestive tract cancers Cancer Metastasis Rev 13 1994 269 277
65. M.J. Thun E.E. Calle M.M. Namboodiri Risk factors for fatal colon cancer in a large prospective study J Natl Cancer Inst 84 1992 1491 1500
66. M. Thun M. Namboodiri E.E. Calle Aspirin use and risk of fatal cancer Cancer Res 53 1993 1322 1327
67. M. Thun M. Namboodiri C. Heath Aspirin use and reduced risk of fatal colon cancer N Engl J Med 325 1991 1593 1596
68. W.R. Waddell G.F. Ganser E.J. Cerise Sulindac for polyposis of the colon Am J Surg 157 1989 175 179
69. W.R. Waddell R.W. Loughry Sulindac for polyposis of the colon J Surg Oncol 24 1983 83 87
70. M.J. Wargovich C.D. Chen C. Harris Inhibition of aberrant crypt growth by non-steroidal anti-inflammatory agents and differentiation agents in the rat colon Int J Cancer 60 1995 515 519
71. J.H. Weisburger B.S. Reddy D.L. Joftes Colorectal Cancer. UICC Technical Report 19 1975 UICC Geneva